Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Brown

Showing results (121-130 of 259) with videos related to

Pageof 26
Sort By:
Ophthalmic Genetics|November 25, 2024
Distinguishing <i>ABCA4</i> from <i>PRPH2</i>-related disease: qualitative analysis of examination and imaging featuresKenneth C Fan, Calvin W Wong, Braden A Nichols, et al.
The New England Journal of Medicine|October 6, 2006
Ranibizumab for neovascular age-related macular degenerationPhilip J Rosenfeld, David M Brown, Jeffrey S Heier, et al.
The New England Journal of Medicine|October 6, 2006
Ranibizumab versus verteporfin for neovascular age-related macular degenerationDavid M Brown, Peter K Kaiser, Mark Michels, et al.
Ophthalmology. Retina|June 30, 2020
Visual Acuity Variability: Comparing Discrepancies between Snellen and ETDRS Measurements among Subjects Entering Prospective TrialsHannah J Yu, Peter K Kaiser, Deneva Zamora, et al.
American Journal of Ophthalmology|December 11, 2012
Treatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II studyPeter A Campochiaro, Roomasa Channa, Brian B Berger, et al.
Frontiers in Microbiology|June 9, 2022
Oil Absorbent Polypropylene Particles Stimulate Biodegradation of Crude Oil by Microbial ConsortiaMadalina M Vita, Paul Iturbe-Espinoza, Matthijs Bonte, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 20, 2010
Lucentis using Visudyne study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degenerationEric Chen, David M Brown, Tien P Wong, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|June 3, 2009
Selected clinical comparisons of spectral domain and time domain optical coherence tomographyDamien M Luviano, Matthew S Benz, Rosa Y Kim, et al.
American Journal of Ophthalmology|October 24, 2007
Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR resultsPeter K Kaiser, David M Brown, Kang Zhang, et al.
Ophthalmology|May 10, 2022
MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal FluidArshad M Khanani, David M Brown, Glenn J Jaffe, et al.
Pageof 26

Showing results (121-130 of 259) with videos related to

Sort By:
Pageof 26
Ophthalmic Genetics|November 25, 2024
Distinguishing <i>ABCA4</i> from <i>PRPH2</i>-related disease: qualitative analysis of examination and imaging featuresKenneth C Fan, Calvin W Wong, Braden A Nichols, et al.
The New England Journal of Medicine|October 6, 2006
Ranibizumab for neovascular age-related macular degenerationPhilip J Rosenfeld, David M Brown, Jeffrey S Heier, et al.
The New England Journal of Medicine|October 6, 2006
Ranibizumab versus verteporfin for neovascular age-related macular degenerationDavid M Brown, Peter K Kaiser, Mark Michels, et al.
Ophthalmology. Retina|June 30, 2020
Visual Acuity Variability: Comparing Discrepancies between Snellen and ETDRS Measurements among Subjects Entering Prospective TrialsHannah J Yu, Peter K Kaiser, Deneva Zamora, et al.
American Journal of Ophthalmology|December 11, 2012
Treatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II studyPeter A Campochiaro, Roomasa Channa, Brian B Berger, et al.
Frontiers in Microbiology|June 9, 2022
Oil Absorbent Polypropylene Particles Stimulate Biodegradation of Crude Oil by Microbial ConsortiaMadalina M Vita, Paul Iturbe-Espinoza, Matthijs Bonte, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 20, 2010
Lucentis using Visudyne study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degenerationEric Chen, David M Brown, Tien P Wong, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|June 3, 2009
Selected clinical comparisons of spectral domain and time domain optical coherence tomographyDamien M Luviano, Matthew S Benz, Rosa Y Kim, et al.
American Journal of Ophthalmology|October 24, 2007
Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR resultsPeter K Kaiser, David M Brown, Kang Zhang, et al.
Ophthalmology|May 10, 2022
MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal FluidArshad M Khanani, David M Brown, Glenn J Jaffe, et al.
Pageof 26